Rein Therapeutics RNTX
NASDAQ RNTX
$0.82 +0.02 (+3.07%)
At close: Aug 21, 2026 · 4:00 PM EDT

Rein Therapeutics (RNTX) Property, Plant & Equipment (Net) (2016 - 2025)

Rein Therapeutics (RNTX) Property, Plant & Equipment (Net) (2016 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Rein Therapeutics 55.49 Mn 55.49 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 1,000.00
Jun 30, 2025 1,000.00
Mar 31, 2025 1,000.00
Mar 31, 2025 1,000.00
Dec 31, 2024 1,000.00
Dec 31, 2024 1,000.00
Sep 30, 2024 1,000.00
Sep 30, 2024 1,000.00
Jun 30, 2024 2,000.00
Jun 30, 2024 2,000.00
Mar 31, 2024 6,000.00
Mar 31, 2024 6,000.00
Dec 31, 2023 19,000.00
Dec 31, 2023 19,000.00
Sep 30, 2023 29,000.00
Sep 30, 2023 29,000.00
Jun 30, 2023 39,000.00
Jun 30, 2023 39,000.00
Mar 31, 2023 52,000.00
Mar 31, 2023 52,000.00